0001943790-22-000001.txt : 20220825 0001943790-22-000001.hdr.sgml : 20220825 20220825144932 ACCESSION NUMBER: 0001943790-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220825 DATE AS OF CHANGE: 20220825 EFFECTIVENESS DATE: 20220825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axon Therapeutics, Inc. CENTRAL INDEX KEY: 0001943790 IRS NUMBER: 874533221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457035 FILM NUMBER: 221196786 BUSINESS ADDRESS: STREET 1: 3993 VIA CANGREJO CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-630-5241 MAIL ADDRESS: STREET 1: 3993 VIA CANGREJO CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001943790 Axon Therapeutics, Inc. 3993 VIA CANGREJO SAN DIEGO CA CALIFORNIA 92130 858-630-5241 DELAWARE None None Corporation true 2022 Pierre Riviere c/o Axon Therapeutics, Inc. 3993 VIA CANGREJO San Diego CA CALIFORNIA 92130 Executive Officer Director David c Dodick c/o Axon Therapeutics, Inc. 3993 VIA CANGREJO San Diego CA CALIFORNIA 92130 Director Frank Porreca c/o Axon Therapeutics, Inc. 3993 VIA CANGREJO San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2022-08-10 false true false 0 5000000 5000000 0 false 2 0 0 0 false Axon Therapeutics, Inc. /s/ Pierre Riviere Pierre Riviere Chief Executive Officer 2022-08-25